Zobrazeno 1 - 3
of 3
pro vyhledávání: '"V Z C, Borba"'
Autor:
L. M. Pechmann, T. H. Jonasson, V. S. Canossa, H. Trierweiler, G. Kisielewicz, R. R. Petterle, C. A. Moreira, V. Z. C. Borba
Publikováno v:
International Journal of Endocrinology, Vol 2020 (2020)
Background. The aim of this study was to compare the prevalence of low muscle mass and sarcopenia in patients with type 2 diabetes mellitus (T2DM) versus paired controls (control group, CG) and the association between sarcopenia and chronic diabetes
Externí odkaz:
https://doaj.org/article/d675d6631f294a199370fb1128b8dd60
Autor:
Marise Lazaretti-Castro, V. Z. C. Borba, Emilia Inoue Sato, Teresa S. Kasamatsu, Sebastião Cezar Radominski, José Gilberto H. Vieira
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 20(3)
We investigated the effects of disease activity on bone metabolism in 36 patients with systemic lupus erythematosus (SLE). Changes in bone remodeling were not explained by corticosteroid use. A high prevalence of 25OHD deficiency in SLE patients indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28eb9461296b23e9645a4d9f62dac11
https://pubmed.ncbi.nlm.nih.gov/18600287
https://pubmed.ncbi.nlm.nih.gov/18600287
Publikováno v:
International journal of clinical practice. 61(6)
Zoledronic acid inhibits bone resorption for up to 12 months. It is not known whether the duration of this antiresorptive effect extends beyond this period of time. The aim of this study was to evaluate the changes in bone turnover at 12 months (T12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::883c5bb02645716c48fb287f04397bb0
https://pubmed.ncbi.nlm.nih.gov/17504370
https://pubmed.ncbi.nlm.nih.gov/17504370